Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
Pfizer, Moderna, GSK, and Sanofi are all working on mRNA flu shots. But how well-suited is the technology for influenza vaccines?
Here are two things that are true.
The world needs more effective flu vaccines. And pharmaceutical companies that learned of the vaccine-making power of the messenger RNA platform during the Covid-19 pandemic need new markets for their technology.
What's Your Reaction?
